Amicus Therapeutics Inc.

9.69
0.01 (0.10%)
At close: Jan 28, 2025, 3:02 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05
Net Income -151.58M -236.57M -250.46M -276.85M -356.39M -349.00M -284.00M -200.04M -132.12M -68.93M -59.63M -48.78M -44.41M -54.94M -6.57M -39.35M -41.17M -46.34M -19.97M
Depreciation & Amortization 7.87M 5.34M 6.21M 8.85M 4.78M 4.22M 3.59M 3.24M 1.83M 1.55M 1.72M 1.71M 1.58M 2.06M 2.13M 1.49M 1.24M 952.45K 667.38K
Stock-Based Compensation 86.08M 76.51M 57.84M 49.15M 44.43M 29.26M 23.10M 17.50M 9.97M 6.01M 6.18M 6.19M 8.68M 6.19M 7.79M 6.45M 2.82M n/a n/a
Other Working Capital -32.46M -10.83M -10.04M -5.60M -18.90M -4.34M -29.73M -926.00K -1.13M -157.00K 6.26M 3.18M -11.16M 32.52M -45.25M -3.82M 44.40M 6.97M 788.61K
Other Non-Cash Items 41.47M 28.01M 2.47M 17.78M 46.57M 14.28M 234.91M 31.37M 4.88M 314.00K 1.99M -625.00K -2.76M 1.41M 195.00K 6.45M 4.13M 4.53M 391.94K
Deferred Income Tax -4.94M 9.00K 34.00K -155.00K -1.42M 6.01M -167.31M -3.74M 952.00K n/a -908.00K n/a n/a 121.00K n/a -6.40M -2.82M n/a n/a
Change in Working Capital -47.99M -39.88M -18.59M -32.06M 11.61M -4.73M -25.79M 1.14M 14.34M 9.39M 4.86M 7.77M -12.51M 31.18M -46.92M -5.49M 50.99M 6.97M 788.61K
Operating Cash Flow -69.09M -166.57M -202.49M -233.29M -250.42M -299.95M -215.49M -150.53M -100.14M -51.67M -45.79M -33.74M -49.42M -13.98M -43.37M -36.86M 15.19M -33.89M -18.12M
Capital Expenditures -7.44M -3.77M -3.88M -3.23M -20.01M -6.31M -4.53M -5.95M -4.82M -238.00K -695.00K -4.32M -1.42M -384.00K -1.81M -2.67M -669.00K -2.03M -3.04M
Acquisitions n/a 3.41M 3.88M 3.23M 20.01M 6.31M n/a n/a -141.06M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments -91.72M -243.25M -341.40M -365.18M -383.88M -578.39M -490.47M -219.93M -289.60M -162.75M -56.56M -118.46M -50.60M -113.66M -98.17M -153.69M -200.74M -62.01M -16.99M
Sales Maturities Of Investments 197.23M 335.93M 424.04M 354.83M 499.05M 463.50M 323.75M 221.37M 290.13M 55.91M 83.34M 83.35M 98.47M 94.60M 131.85M 178.10M 126.37M 37.44M 3.09M
Other Investing Acitivies n/a 3.41M -3.88M -3.23M -20.01M -6.31M -166.72M 1.44M 534.00K -106.84M 26.78M -35.11M n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow 98.06M 92.32M 78.76M -13.58M 95.15M -121.20M -171.24M -4.51M -145.34M -107.08M 26.08M -39.43M 46.45M -19.44M 31.87M 21.75M -75.04M -26.60M -16.94M
Debt Repayment -20.96M -283.00K -479.00K 230.60M 19.45M 146.26M -308.00K 192.34M 34.71M -299.00K 14.49M -347.00K -1.29M -1.56M 2.71M -1.53M -1.39M -880.75K -272.70K
Common Stock Repurchased n/a -11.49M n/a -10.03M -3.23M -2.83M -1.60M -1.28M -2.04M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -10.30M n/a 12.80M 32.25M 9.05M 9.93M 4.71M -16.70M 13.14M 3.67M -110.00K 1.63M 359.00K 9.00K 60.00K n/a 546.00K 3.43M 1.11M
Financial Cash Flow 61.68M -7.46M 212.07M 262.86M 217.50M 450.77M 247.43M 272.71M 290.89M 139.18M 29.38M 81.48M -934.00K 43.66M 2.77M -998.00K 91.91M 66.17M 41.25M
Net Cash Flow 96.96M -96.34M 83.29M 19.82M 63.97M 31.14M -137.97M 117.54M 45.41M -19.57M 9.67M 8.30M -3.90M 10.23M -8.73M -16.11M 32.06M 5.68M 6.19M
Free Cash Flow -76.53M -170.34M -206.38M -236.52M -270.43M -306.26M -220.01M -156.49M -104.96M -51.91M -46.49M -38.07M -50.84M -14.37M -45.18M -39.53M 14.52M -35.92M -21.16M